Barr Scraps Seasonale Ad Revisions, Starts On New DTC Campaign
This article was originally published in The Pink Sheet Daily
Executive Summary
The company attributes a slowdown in growth for the extended-regimen oral contraceptive to the hiatus in direct-to-consumer advertising. The DTC spots were pulled after FDA objected to the original ad and the revised version. New ads will debut in late spring or early summer, CEO Downey says.